Explore more publications!
Maryland Tech Journal
Submit Press Release

Maryland Tech Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Tech Journal.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on September 24, 2025

PTFS Awarded Contract by ABMC for Historic Photo Conversion Project at Honolulu Memorial and Manila American Cemetery
September 24, 2025

PTFS Awarded Contract by ABMC for Historic Photo Conversion Project at Honolulu Memorial and Manila American Cemetery

Indeterminate EIN Presswire
Qualcomm Embeds Truepic’s Secure Media Library as Feature in Snapdragon 8 Elite Gen 5
September 24, 2025

Qualcomm Embeds Truepic’s Secure Media Library as Feature in Snapdragon 8 Elite Gen 5

Indeterminate GlobeNewswire
Camelot Secure And DigiFlight Named As Finalists In Three Categories For 2025 Cybersecurity Awards
September 24, 2025

Camelot Secure And DigiFlight Named As Finalists In Three Categories For 2025 Cybersecurity Awards

Indeterminate EIN Presswire
ServiceTitan Unveils Major Product Expansions Across AI, Financial Tools, Construction, and CRM at Pantheon 2025
September 24, 2025

ServiceTitan Unveils Major Product Expansions Across AI, Financial Tools, Construction, and CRM at Pantheon 2025

Indeterminate GlobeNewswire
Verano to Report Third Quarter 2025 Financial Results on October 29, 2025
September 24, 2025

Verano to Report Third Quarter 2025 Financial Results on October 29, 2025

Indeterminate GlobeNewswire
SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury
September 24, 2025

SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury

Indeterminate GlobeNewswire
uniQure Announces $200 Million Proposed Public Offering
September 24, 2025

uniQure Announces $200 Million Proposed Public Offering

Indeterminate GlobeNewswire
Diginex Provides Update on Acquisition Strategy
September 24, 2025

Diginex Provides Update on Acquisition Strategy

Indeterminate GlobeNewswire
Shareholders of Verona Pharma Approve Proposed Acquisition by Merck
September 24, 2025

Shareholders of Verona Pharma Approve Proposed Acquisition by Merck

Indeterminate GlobeNewswire
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
September 24, 2025

Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association

Indeterminate GlobeNewswire
Kodiak Completes Business Combination with Ares Acquisition Corporation II to Accelerate Journey as a Leading AI-Powered Autonomous Vehicle Technology Company
September 24, 2025

Kodiak Completes Business Combination with Ares Acquisition Corporation II to Accelerate Journey as a Leading AI-Powered Autonomous Vehicle Technology Company

Indeterminate GlobeNewswire
Immuneering Announces Proposed Underwritten Public Offering of Class A Common Stock and Pre-Funded Warrants and Proposed Concurrent Private Placement of Class A Common Stock and Class B Common Stock to Sanofi
September 24, 2025

Immuneering Announces Proposed Underwritten Public Offering of Class A Common Stock and Pre-Funded Warrants and Proposed Concurrent Private Placement of Class A Common Stock and Class B Common Stock to Sanofi

Indeterminate GlobeNewswire
Invivyd Appoints Paul B. Bolno, M.D. to Its Board of Directors
September 24, 2025

Invivyd Appoints Paul B. Bolno, M.D. to Its Board of Directors

Indeterminate GlobeNewswire
Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP
September 24, 2025

Immuneering Announces Extraordinary 86% Overall Survival at 9 Months in First-Line Pancreatic Cancer Patients Treated with Atebimetinib + mGnP

Indeterminate GlobeNewswire
Inventiva to Host Analyst and Investor Event on October 8, 2025
September 24, 2025

Inventiva to Host Analyst and Investor Event on October 8, 2025

Indeterminate GlobeNewswire
HiBob Celebrates 1,900+ 5‑Star G2 Reviews, Cementing Its Role as the Best HR and Payroll Software for Small Business
September 24, 2025

HiBob Celebrates 1,900+ 5‑Star G2 Reviews, Cementing Its Role as the Best HR and Payroll Software for Small Business

Indeterminate GlobeNewswire
SoCalBio Investor & Partnership Conference to Feature Keynotes from SetPoint CEO Murthy Simhambhatla, PhD, and MedTech Industry Deal-Maker Ray Cohen
September 24, 2025

SoCalBio Investor & Partnership Conference to Feature Keynotes from SetPoint CEO Murthy Simhambhatla, PhD, and MedTech Industry Deal-Maker Ray Cohen

Indeterminate GlobeNewswire
L’Île-du-Prince-Édouard devient la première province à intégrer les soins à domicile aux systèmes hospitaliers grâce à AlayaCare
September 24, 2025

L’Île-du-Prince-Édouard devient la première province à intégrer les soins à domicile aux systèmes hospitaliers grâce à AlayaCare

Indeterminate GlobeNewswire
Exterro lance FTK Imager Pro, permettant aux enquêteurs du monde entier d’accéder plus rapidement aux données cryptées
September 24, 2025

Exterro lance FTK Imager Pro, permettant aux enquêteurs du monde entier d’accéder plus rapidement aux données cryptées

Indeterminate GlobeNewswire
AI/R Celebrates 500 Oracle AI Agent Studio Certifications With Fusion Customers at “Winning the AI Race” Event in Las Vegas
September 24, 2025

AI/R Celebrates 500 Oracle AI Agent Studio Certifications With Fusion Customers at “Winning the AI Race” Event in Las Vegas

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions